Healthcare and Pharmaceuticals industry

Retinal Biosimilars Market 2020 By Manufacturers, Regions, Type, And Application, Forecast To 2026




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Summary

The global Retinal Biosimilars Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

The Retinal Biosimilars Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Retinal Biosimilars Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Novartis (Sandoz)
  • Takeda
  • Bayer
  • Genentech
  • Pfenex
  • Reliance Life Sciences
  • Hetero Drugs
  • Intas Pharmaceuticals
  • Santo Holding
  • Regeneron Pharmaceuticals

By the Product Type, the market is primarily segmented into:

  • Macular Degeneration Drugs
  • Diabetic Eye Disease Drugs
  • Macular Pucker Drugs
  • Others

By Applications, the market is segmented into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

The Report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Retinal Biosimilars Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Retinal Biosimilars Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Retinal Biosimilars Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact growth of the Retinal Biosimilars Market

The Retinal Biosimilars Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Retinal Biosimilars Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Table of Contents

Retinal Biosimilars Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Retinal Biosimilars
1.1 Retinal Biosimilars Market Overview
1.1.1 Retinal Biosimilars Product Scope
1.1.2 Market Status and Outlook
1.2 Global Retinal Biosimilars Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Retinal Biosimilars Market by Type
1.3.1 Global Retinal Biosimilars Revenue (Million US$) and Growth Comparison by Type (2014-2025)
1.3.2 Global Retinal Biosimilars Revenue Market Share by Type in 2018
1.3.3 Macular Degeneration Drugs
1.3.4 Diabetic Eye Disease Drugs
1.3.5 Macular Pucker Drugs
1.3.6 Others
1.4 Retinal Biosimilars Market by End Users/Application
1.4.1 Hospital Pharmacies
1.4.2 Retail Pharmacies
1.4.3 Online Pharmacies

2 Global Retinal Biosimilars Competition Analysis by Players
2.1 Global Retinal Biosimilars Market Size (Million US$) by Players (2014-2019)
2.2 Competitive Status
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 Mergers & Acquisitions, Expansion Plans

3 Company (Top Players) Profiles and Key Data
3.1 Novartis (Sandoz)
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Retinal Biosimilars Revenue (Value) (2014-2019)
3.1.5 Recent Developments
3.2 Takeda
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Retinal Biosimilars Revenue (Value) (2014-2019)
3.2.5 Recent Developments
3.3 Bayer
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Retinal Biosimilars Revenue (Value) (2014-2019)
3.3.5 Recent Developments
3.4 Genentech
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Retinal Biosimilars Revenue (Value) (2014-2019)
3.4.5 Recent Developments
3.5 Pfenex
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Retinal Biosimilars Revenue (Value) (2014-2019)
3.5.5 Recent Developments
3.6 Reliance Life Sciences
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Retinal Biosimilars Revenue (Value) (2014-2019)
3.6.5 Recent Developments
3.7 Hetero Drugs
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Retinal Biosimilars Revenue (Value) (2014-2019)
3.7.5 Recent Developments
3.8 Intas Pharmaceuticals
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Retinal Biosimilars Revenue (Value) (2014-2019)
3.8.5 Recent Developments
3.9 Santo Holding
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Retinal Biosimilars Revenue (Value) (2014-2019)
3.9.5 Recent Developments
3.10 Regeneron Pharmaceuticals
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Retinal Biosimilars Revenue (Value) (2014-2019)
3.10.5 Recent Developments

4 Global Retinal Biosimilars Market Size by Type and Application (2014-2019)
4.1 Global Retinal Biosimilars Market Size by Type (2014-2019)
4.2 Global Retinal Biosimilars Market Size by Application (2014-2019)
4.3 Potential Application of Retinal Biosimilars in Future
4.4 Top Consumer/End Users of Retinal Biosimilars

5 North America Retinal Biosimilars Development Status and Outlook
5.1 North America Retinal Biosimilars Market Size (2014-2019)
5.2 North America Retinal Biosimilars Market Size and Market Share by Players (2014-2019)
5.3 North America Retinal Biosimilars Market Size by Application (2014-2019)

6 Europe Retinal Biosimilars Development Status and Outlook
6.1 Europe Retinal Biosimilars Market Size (2014-2019)
6.2 Europe Retinal Biosimilars Market Size and Market Share by Players (2014-2019)
6.3 Europe Retinal Biosimilars Market Size by Application (2014-2019)

7 China Retinal Biosimilars Development Status and Outlook
7.1 China Retinal Biosimilars Market Size (2014-2019)
7.2 China Retinal Biosimilars Market Size and Market Share by Players (2014-2019)
7.3 China Retinal Biosimilars Market Size by Application (2014-2019)

8 Rest of Asia Pacific Retinal Biosimilars Development Status and Outlook
8.1 Rest of Asia Pacific Retinal Biosimilars Market Size (2014-2019)
8.2 Rest of Asia Pacific Retinal Biosimilars Market Size and Market Share by Players (2014-2019)
8.3 Rest of Asia Pacific Retinal Biosimilars Market Size by Application (2014-2019)

9 Central & South America Retinal Biosimilars Development Status and Outlook
9.1 Central & South America Retinal Biosimilars Market Size (2014-2019)
9.2 Central & South America Retinal Biosimilars Market Size and Market Share by Players (2014-2019)
9.3 Central & South America Retinal Biosimilars Market Size by Application (2014-2019)

10 Middle East & Africa Retinal Biosimilars Development Status and Outlook
10.1 Middle East & Africa Retinal Biosimilars Market Size (2014-2019)
10.2 Middle East & Africa Retinal Biosimilars Market Size and Market Share by Players (2014-2019)
10.3 Middle East & Africa Retinal Biosimilars Market Size by Application (2014-2019)

11 Market Forecast by Regions and Application (2019-2025)
11.1 Global Retinal Biosimilars Market Size by Regions (2019-2025)
11.1.1 North America Retinal Biosimilars Revenue and Growth Rate (2019-2025)
11.1.2 Europe Retinal Biosimilars Revenue and Growth Rate (2019-2025)
11.1.3 China Retinal Biosimilars Revenue and Growth Rate (2019-2025)
11.1.4 Rest of Asia Pacific Retinal Biosimilars Revenue and Growth Rate (2019-2025)
11.1.5 Central & South America Retinal Biosimilars Revenue and Growth Rate (2019-2025)
11.1.6 Middle East & Africa Retinal Biosimilars Revenue and Growth Rate (2019-2025)
11.2 Global Retinal Biosimilars Market Size by Application (2019-2025)
11.3 The Market Drivers in Future

12 Retinal Biosimilars Market Dynamics
12.1 Industry Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porters Five Forces Analysis

13 Research Finding /Conclusion

14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List

List of Table
List of Tables and Figures

Figure Global Retinal Biosimilars Market Size (Million USD) Status and Outlook (2014-2025)
Table Global Retinal Biosimilars Market Size (Million USD) and Growth Rate by Regions (2014-2025)
Figure Global Retinal Biosimilars Market Share by Regions (2014-2019)
Figure North America Retinal Biosimilars Market Size (Million USD) and Growth Rate (2014-2019)
Figure Europe Retinal Biosimilars Market Size (Million USD) and Growth Rate (2014-2019)
Figure China Retinal Biosimilars Market Size (Million USD) and Growth Rate (2014-2019)
Figure Rest of Asia Pacific Retinal Biosimilars Market Size (Million USD) and Growth Rate (2014-2019)
Figure Central & South America Retinal Biosimilars Market Size (Million USD) and Growth Rate (2014-2019)
Figure Middle East & Africa Retinal Biosimilars Market Size (Million USD) and Growth Rate (2014-2019)
Figure Global Retinal Biosimilars Market Share by Type in 2018 & 2025
Figure Macular Degeneration Drugs Market Size (Million USD) and Growth Rate (2014-2019)
Figure Diabetic Eye Disease Drugs Market Size (Million USD) and Growth Rate (2014-2019)
Figure Macular Pucker Drugs Market Size (Million USD) and Growth Rate (2014-2019)
Figure Others Market Size (Million USD) and Growth Rate (2014-2019)
Table Global Retinal Biosimilars Market Size (Million US$) Comparison by Application (2014-2025)
Figure Global Retinal Biosimilars Market Share by Application in 2018 & 2025
Figure Retinal Biosimilars Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2014-2019)
Figure Retinal Biosimilars Market Size (Million USD) and Growth Rate in Retail Pharmacies (2014-2019)
Figure Retinal Biosimilars Market Size (Million USD) and Growth Rate in Online Pharmacies (2014-2019)
Table Global Retinal Biosimilars Revenue (Million US$) by Players (2014-2019)
Table Global Retinal Biosimilars Revenue Market Share by Players (2014-2019)
Eigure Retinal Biosimilars Market Size Share by Players in 2018
Table Global Retinal Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Global Top 5 Players Retinal Biosimilars Market Share in 2018
Figure Global Top 10 Players Retinal Biosimilars Market Share in 2018
Table Retinal Biosimilars Key Players Product/Service
Table Mergers & Acquisitions, Expansion Plans
Table Novartis (Sandoz) Basic Information List
Table Novartis (Sandoz) Description and Business Overview
Table Novartis (Sandoz) Retinal Biosimilars Products, Services and Solutions
Table Revenue (Million US$) in Retinal Biosimilars Business of Novartis (Sandoz) (2014-2019)
Table Novartis (Sandoz) Retinal Biosimilars Recent Developments
Table Takeda Basic Information List
Table Takeda Description and Business Overview
Table Takeda Retinal Biosimilars Products, Services and Solutions
Table Revenue (Million US$) in Retinal Biosimilars Business of Takeda (2014-2019)
Table Takeda Retinal Biosimilars Recent Developments
Table Bayer Basic Information List
Table Bayer Description and Business Overview
Table Bayer Retinal Biosimilars Products, Services and Solutions
Table Revenue (Million US$) in Retinal Biosimilars Business of Bayer (2014-2019)
Table Bayer Retinal Biosimilars Recent Developments
Table Genentech Basic Information List
Table Genentech Description and Business Overview
Table Genentech Retinal Biosimilars Products, Services and Solutions
Table Revenue (Million US$) in Retinal Biosimilars Business of Genentech (2014-2019)
Table Genentech Retinal Biosimilars Recent Developments
Table Pfenex Basic Information List
Table Pfenex Description and Business Overview
Table Pfenex Retinal Biosimilars Products, Services and Solutions
Table Revenue (Million US$) in Retinal Biosimilars Business of Pfenex (2014-2019)
Table Pfenex Retinal Biosimilars Recent Developments
Table Reliance Life Sciences Basic Information List
Table Reliance Life Sciences Description and Business Overview
Table Reliance Life Sciences Retinal Biosimilars Products, Services and Solutions
Table Revenue (Million US$) in Retinal Biosimilars Business of Reliance Life Sciences (2014-2019)
Table Reliance Life Sciences Retinal Biosimilars Recent Developments
Table Hetero Drugs Basic Information List
Table Hetero Drugs Description and Business Overview
Table Hetero Drugs Retinal Biosimilars Products, Services and Solutions
Table Revenue (Million US$) in Retinal Biosimilars Business of Hetero Drugs (2014-2019)
Table Hetero Drugs Retinal Biosimilars Recent Developments
Table Intas Pharmaceuticals Basic Information List
Table Intas Pharmaceuticals Description and Business Overview
Table Intas Pharmaceuticals Retinal Biosimilars Products, Services and Solutions
Table Revenue (Million US$) in Retinal Biosimilars Business of Intas Pharmaceuticals (2014-2019)
Table Intas Pharmaceuticals Retinal Biosimilars Recent Developments
Table Santo Holding Basic Information List
Table Santo Holding Description and Business Overview
Table Santo Holding Retinal Biosimilars Products, Services and Solutions
Table Revenue (Million US$) in Retinal Biosimilars Business of Santo Holding (2014-2019)
Table Santo Holding Retinal Biosimilars Recent Developments
Table Regeneron Pharmaceuticals Basic Information List
Table Regeneron Pharmaceuticals Description and Business Overview
Table Regeneron Pharmaceuticals Retinal Biosimilars Products, Services and Solutions
Table Revenue (Million US$) in Retinal Biosimilars Business of Regeneron Pharmaceuticals (2014-2019)
Table Regeneron Pharmaceuticals Retinal Biosimilars Recent Developments
Table Global Retinal Biosimilars Market Size by Type (2014-2019) (Million US$)
Figure Global Retinal Biosimilars Revenue Market Share by Type in 2018
Table Global Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Figure Global Retinal Biosimilars Revenue Market by Application in 2018
Table Top Consumer/End Users of Retinal Biosimilars
Figure North America Retinal Biosimilars Market Size and Growth Rate(2014-2019) (Million USD)
Table North America Retinal Biosimilars Market Size by Players (2014-2019)(Million US$)
Figure North America Retinal Biosimilars Market Size Share by Players in 2018
Table North America Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Figure North America Retinal Biosimilars Revenue Market Share by Application (2014-2019)
Figure North America Retinal Biosimilars Market Size Share by Application in 2018
Figure Europe Retinal Biosimilars Market Size and Growth Rate(2014-2019) (Million USD)
Table Europe Retinal Biosimilars Market Size by Players (2014-2019)(Million US$)
Figure Europe Retinal Biosimilars Market Size Share by Players in 2018
Table Europe Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Figure Europe Retinal Biosimilars Revenue Market Share by Application (2014-2019)
Figure Europe Retinal Biosimilars Market Size Share by Application in 2018
Figure China Retinal Biosimilars Market Size and Growth Rate(2014-2019) (Million USD)
Table China Retinal Biosimilars Market Size by Players (2014-2019)(Million US$)
Figure China Retinal Biosimilars Market Size Share by Players in 2018
Table China Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Figure China Retinal Biosimilars Revenue Market Share by Application (2014-2019)
Figure China Retinal Biosimilars Market Size Share by Application in 2018
Figure Rest of Asia Pacific Retinal Biosimilars Market Size and Growth Rate(2014-2019) (Million USD)
Table Rest of Asia Pacific Retinal Biosimilars Market Size by Players (2014-2019)(Million US$)
Figure Rest of Asia Pacific Retinal Biosimilars Market Size Share by Players in 2018
Table Rest of Asia Pacific Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Figure Rest of Asia Pacific Retinal Biosimilars Revenue Market Share by Application (2014-2019)
Figure Rest of Asia Pacific Retinal Biosimilars Market Size Share by Application in 2018
Figure Central & South America Retinal Biosimilars Market Size and Growth Rate(2014-2019) (Million USD)
Table Central & South America Retinal Biosimilars Market Size by Players (2014-2019)(Million US$)
Figure Central & South America Retinal Biosimilars Market Size Share by Players in 2018
Table Central & South America Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Figure Central & South America Retinal Biosimilars Revenue Market Share by Application (2014-2019)
Figure Central & South America Retinal Biosimilars Market Size Share by Application in 2018
Figure Middle East & Africa Retinal Biosimilars Market Size and Growth Rate(2014-2019) (Million USD)
Table Middle East & Africa Retinal Biosimilars Market Size by Players (2014-2019)(Million US$)
Figure Middle East & Africa Retinal Biosimilars Market Size Share by Players in 2018
Table Middle East & Africa Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Figure Middle East & Africa Retinal Biosimilars Revenue Market Share by Application (2014-2019)
Figure Middle East & Africa Retinal Biosimilars Market Size Share by Application in 2018
Figure Global Retinal Biosimilars Market Size and Growth Rate (Value) (2019-2025) (Million US$)
Table Global Retinal Biosimilars Market Size by Regions (2019-2025) (Million US$)
Figure Global Retinal Biosimilars Market Size Share by Regions (2019-2025)
Figure Global Retinal Biosimilars Market Size Share by Regions in 2025
Figure North America Retinal Biosimilars Revenue (Million USD) and Growth Rate (2019-2025)
Figure Europe Retinal Biosimilars Revenue (Million USD) and Growth Rate (2019-2025)
Figure China Retinal Biosimilars Revenue (Million USD) and Growth Rate (2019-2025)
Figure Rest of Asia Pacific Retinal Biosimilars Revenue (Million USD) and Growth Rate (2019-2025)
Figure Central & South America Retinal Biosimilars Revenue (Million USD) and Growth Rate (2019-2025)
Figure Middle East & Africa Retinal Biosimilars Revenue (Million USD) and Growth Rate (2019-2025)
Table Global Retinal Biosimilars Market Size by Application (2019-2025) (Million USD)
Figure Global Retinal Biosimilars Market Size by Application (2019-2025)
Figure Global Retinal Biosimilars Market Size by Application in 2025
Table Global Retinal Biosimilars Market Size by Type (2019-2025) (Million US$)
Figure Global Retinal Biosimilars Market Size by Type (2019-2025)
Figure Global Retinal Biosimilars Market Size by Type in 2025
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure Porter's Five Forces Analysis
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
 



Contact Us

U.S.A :  +1-415-871-0703

UK :  +44-203-289-4040

JAPAN :  +81-50-5539-1737


Drop Us an email at

[email protected]

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.